Arati Prabhu

406 total citations
28 papers, 318 citations indexed

About

Arati Prabhu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Arati Prabhu has authored 28 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Arati Prabhu's work include Synthesis and biological activity (5 papers), Computational Drug Discovery Methods (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Arati Prabhu is often cited by papers focused on Synthesis and biological activity (5 papers), Computational Drug Discovery Methods (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Arati Prabhu collaborates with scholars based in India, Japan and United States. Arati Prabhu's co-authors include André Venot, Geert‐Jan Boons, Tabassum Khan, Mariam S. Degani, Ramakrishna V. Hosur, Alpeshkumar K. Malde, Amarnath Chatterjee, Evans C. Coutinho, Anindya Ghosh‐Roy and Heike Goebel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Organic Letters.

In The Last Decade

Arati Prabhu

25 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arati Prabhu India 11 189 108 54 46 28 28 318
Cliff C. Cheng United States 10 204 1.1× 74 0.7× 28 0.5× 49 1.1× 26 0.9× 13 304
Anil K. Padyana United States 12 358 1.9× 59 0.5× 60 1.1× 40 0.9× 26 0.9× 15 511
Scott E. Warder United States 16 416 2.2× 75 0.7× 37 0.7× 45 1.0× 26 0.9× 27 590
Michael Mrosek United Kingdom 6 252 1.3× 52 0.5× 56 1.0× 38 0.8× 9 0.3× 6 365
Piyusha P. Pagare United States 11 165 0.9× 76 0.7× 74 1.4× 24 0.5× 25 0.9× 34 380
Hitoshi Sakashita Japan 10 220 1.2× 80 0.7× 18 0.3× 54 1.2× 30 1.1× 19 409
Ashwini K. Devkota United States 14 361 1.9× 69 0.6× 27 0.5× 43 0.9× 30 1.1× 23 513
Katherine T. Barglow United States 7 360 1.9× 165 1.5× 45 0.8× 27 0.6× 33 1.2× 8 478
Adrien Herlédan France 12 260 1.4× 50 0.5× 58 1.1× 38 0.8× 35 1.3× 21 441
Jesús Vázquez Spain 10 265 1.4× 100 0.9× 21 0.4× 54 1.2× 21 0.8× 12 368

Countries citing papers authored by Arati Prabhu

Since Specialization
Citations

This map shows the geographic impact of Arati Prabhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arati Prabhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arati Prabhu more than expected).

Fields of papers citing papers by Arati Prabhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arati Prabhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arati Prabhu. The network helps show where Arati Prabhu may publish in the future.

Co-authorship network of co-authors of Arati Prabhu

This figure shows the co-authorship network connecting the top 25 collaborators of Arati Prabhu. A scholar is included among the top collaborators of Arati Prabhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arati Prabhu. Arati Prabhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prabhu, Arati, et al.. (2025). Nanocarrier-Mediated dermal drug delivery for skin disorders. IP Indian Journal of Clinical and Experimental Dermatology. 11(1). 10–21.
2.
Prabhu, Arati, et al.. (2024). Exercise, exerkines and exercise mimetic drugs: Molecular mechanisms and therapeutics. Life Sciences. 359. 123225–123225. 4 indexed citations
3.
4.
Prabhu, Arati, et al.. (2023). Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease. Neurochemistry International. 163. 105486–105486. 8 indexed citations
5.
Gharat, Sankalp, et al.. (2023). Mucoadhesive Oro-Gel–Containing Chitosan Lipidic Nanoparticles for the Management of Oral Squamous Cell Carcinoma. Journal of Pharmaceutical Innovation. 18(3). 1298–1315. 4 indexed citations
6.
Prabhu, Arati, et al.. (2023). Targets, trials and tribulations in Alzheimer therapeutics. European Journal of Pharmacology. 962. 176230–176230. 9 indexed citations
7.
Prabhu, Arati, et al.. (2023). Design, synthesis, metal chelation potential and biological evaluation of pyridine chalcones as multi-target-directed ligands against Alzheimer's disease. Journal of Molecular Structure. 1294. 136498–136498. 8 indexed citations
8.
Jadhav, Mrunal & Arati Prabhu. (2022). Metallic and polymeric green nanoplatforms in oncology. Journal of Applied Microbiology. 134(1). 3 indexed citations
9.
Prabhu, Arati, et al.. (2022). Smart nanocomposite assemblies for multimodal cancer theranostics. International Journal of Pharmaceutics. 618. 121697–121697. 17 indexed citations
10.
Prabhu, Arati, et al.. (2022). Forced Degradation Studies on Agents of Therapeutic Interest. SHILAP Revista de lepidopterología. 22–22.
11.
Prabhu, Arati, et al.. (2021). The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics. Experimental and Molecular Pathology. 124. 104723–104723. 14 indexed citations
12.
Prabhu, Arati, et al.. (2019). Docking structurally similar analogues: Dealing with the false-positive. Journal of Molecular Graphics and Modelling. 93. 107451–107451. 15 indexed citations
13.
Degani, Mariam S., et al.. (2018). Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity. Journal of Biomolecular Structure and Dynamics. 37(12). 3109–3121. 23 indexed citations
14.
Dunkern, Torsten, et al.. (2012). Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5′-monophosphate dehydrogenase II (IMPDH II) inhibitors. Journal of Computer-Aided Molecular Design. 26(11). 1277–1292. 16 indexed citations
15.
Quintini, Gianluca, et al.. (2010). Synthesis and biological evaluation of novel (4 or 5-aryl)pyrazolyl-indoles as inhibitors of interleukin-2 inducible T-cell kinase (ITK). Bioorganic & Medicinal Chemistry. 18(12). 4547–4559. 30 indexed citations
16.
Verma, Jitender, Vijay M. Khedkar, Arati Prabhu, et al.. (2008). A comprehensive analysis of the thermodynamic events involved in ligand–receptor binding using CoRIA and its variants. Journal of Computer-Aided Molecular Design. 22(2). 91–104. 18 indexed citations
17.
Chatterjee, Amarnath, et al.. (2006). Equilibrium unfolding of DLC8 monomer by urea and guanidine hydrochloride: Distinctive global and residue level features. Biochimie. 89(1). 117–134. 25 indexed citations
18.
Prabhu, Arati, Evans C. Coutinho, & Sudha Srivastava. (2005). The amino-terminal domain of human signal transducers and activators of transcription 1: Overexpression, purification and characterization. Journal of Biosciences. 30(5). 611–618. 2 indexed citations
19.
Prabhu, Arati, Alpeshkumar K. Malde, Evans C. Coutinho, & Sudha Srivastava. (2005). Solution conformation of Substance P antagonists—[d-Arg1, d-Trp7,9, Leu11]-SP, [d-Arg1, d-Pro2, d-Trp7,9, Leu11]-SP and [d-Pro2, d-Trp7,9]-SP by CD, NMR and MD simulations. Peptides. 26(5). 875–885. 7 indexed citations
20.
Prabhu, Arati, André Venot, & Geert‐Jan Boons. (2003). New Set of Orthogonal Protecting Groups for the Modular Synthesis of Heparan Sulfate Fragments. Organic Letters. 5(26). 4975–4978. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cliff C. Cheng Breakdown of academic impact, for papers by Anil K. Padyana Breakdown of academic impact, for papers by Scott E. Warder Breakdown of academic impact, for papers by Michael Mrosek Breakdown of academic impact, for papers by Piyusha P. Pagare Breakdown of academic impact, for papers by Hitoshi Sakashita Breakdown of academic impact, for papers by Ashwini K. Devkota Breakdown of academic impact, for papers by Katherine T. Barglow Breakdown of academic impact, for papers by Adrien Herlédan Breakdown of academic impact, for papers by Jesús Vázquez
Rankless by CCL
2026